Short description
Q32 Bio is a biotechnology company that develops treatments for patients with severe autoimmune and inflammatory diseases.
Description
Q32 Bio is a biotechnology company developing treatments for patients with severe autoimmune and inflammatory diseases. Q32 Bio is addressing dysregulation to help patients take back control of their lives in diseases with few to no treatment options, or those diseases where current therapeutics provide inadequate relief.
Q32 Bio consists of a team of scientists and industry veterans with strong expertise in immunology. The team has a strong track record of discovering and developing new and innovative therapies.
Last funding
Noway Youcantaccess
Sign in for full access
Total funding
$$3123123
Sign in for full access
Location
Cambridge, Massachusetts, United States, North America
Founded on
January 1, 2017
Exited on
March 25
Went public on
March 25
Stock symbol
QTTB
Non-profit?
No
Acquired?
No
Employees count
11-50
Revenue range
$34056 - 789030
Sign in for full access
Investors
Noaccessforu, Noaccessforu, Cannot Access, Absolutely Noaccess, Blurry Noaccess, Noaccess, Nopepepe, Noaccess, Nopepepe, No Way, Noaccess, Uh Ohhhh
Sign in for full access
Founders
Shelia Violette